2023 Form 5500 filing — Spi Pharma 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011125351NAL0036963472001) for Spi Pharma 401(K) Plan, reported by Spi Pharma under EIN 51-0108237 and plan number 002. It reports 364 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241011125351NAL0036963472001
Filing year
2023
Form type
2
Plan sponsor
Spi Pharma
EIN
51-0108237
Plan number
002
Location
Wilmington, DE
Participants
364
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$50,223,019
Total liabilities (EOY)
$0
Net assets (EOY)
$50,223,019
Employer contributions
$1,921,521
Participant contributions
$1,869,238
Total income / additions
$11,519,570
Benefits paid
$4,141,591
Administrative expenses
$116,475
Total expenses
$4,266,521
Net increase / (decrease)
$7,253,049
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
John Hancock Retirement Plan SrvcsRETAINED BY EMPLOYER$60,764$0
Snowden Capital Advisors LLCRETAINED BY CLIENT$40,000not reported in the loaded dataset
Gelman, Rosenberg And Freedman, PcRETAINED BY CLIENT$15,711not reported in the loaded dataset

Related Form 5500 pages